Tela Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $20,197 | $18,520 | $17,649 | $18,957 |
Gross Profit | 14,105 | 12,512 | 11,221 | 12,858 |
EBITDA | -8,432 | -9,726 | -7,803 | -8,765 |
EBIT | -8,702 | -9,993 | -8,069 | -9,028 |
Net Income | -9,923 | -11,264 | -9,208 | -10,372 |
Net Change In Cash | 20,197 | 18,520 | 17,649 | 18,957 |
Free Cash Flow | -8,019 | -9,757 | -7,795 | -9,105 |
Cash | 34,977 | 42,833 | 52,670 | 17,301 |
Basic Shares | 45,365 | 45,267 | 40,074 | 24,703 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $69,300 | $58,453 | $41,418 | $29,463 |
Gross Profit | 46,488 | 40,112 | 27,044 | 18,813 |
EBITDA | -31,683 | -40,633 | -39,058 | -29,144 |
EBIT | -32,695 | -41,441 | -40,245 | -29,679 |
Net Income | -37,841 | -46,664 | -44,337 | -33,276 |
Net Change In Cash | 69,300 | 58,453 | 41,418 | 29,463 |
Cost of Revenue | -1,768 | -30,474 | ||
Free Cash Flow | -42,584 | -41,468 | -42,620 | -31,059 |
Cash | 52,670 | 46,729 | 42,019 | 43,931 |
Basic Shares | 28,526 | 22,868 | 16,267 | 14,473 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.22 |
2025-03-31 | -$0.25 |
2024-12-31 | -$0.23 |
